Dislocations have impact on quality of life, but it is difficult to quantify this impact for each patient. The Quality-of-Life Time Trade-Off assesses the percentage of a patient's remaining life that the patient would be willing to trade for perfect health [1]. This technique has been used for non-unions [2], but never proposed for dislocation. 154 patients (with 3 recurrent dislocations) undergoing revision were asked to choose between living with their associated dislocation risk or trading a portion of their life expectancy for a period of perfect health without dislocation, thus determining their Quality-of-Life score. This score may range from 0.1 (willing to trade nine years among 10) to 1.0 (unwilling to trade any years). Additionally, patients were assessed on their willingness to trade implant survival time for a reduced risk of dislocation, considering various implant options that might offer lower (but not necessary) survival time before revision than the theoretical best (for the surgeon) “standard” implant, thus determining a “Survival Implant Quality” score. Patients diagnosed with 3 hip dislocations have a low health-related quality of life. The score of our “dislocation” cohort was average 0.77 with patients willing to trade average 23% of remaining lifespan for perfect health (range 48% to 12%). This score is below that (0.88) of illnesses type-I diabetes mellitus [3] and just higher than tibial non-union (0.68) score [2]. The mean “Survival Implant Quality” score of our recurrent dislocation cohort was 0.71 (range 0.59 to 0.78) which means that patients accept to trade average 3 years (range 2 to 4 years) among 10 theoretical years of survival of the implant. Hip dislocation has a devastating impact that can be quantified for each patient when discussing revision and choice of implants for instability. For references, please contact the author directly.
The purpose was to determine the lifetime risk of re-operation due to specific complications related to dual mobility using re-operation as a competing risk, excluding loosening, periprosthetic fracture, and infection. 1503 mono-block dual mobility total hip arthroplasty (DM-THAs). Defining the re-operation when anesthesia (for dislocation) and revision when the implant changed. Surgery (801 for primary, 702 for revision with 201 for recurrent dislocation and 501 for loosening) performed between 1990 and 2020 in average 81-year-old (range 50–102) patients, with 522 living patients at 10 years follow-up.
The 522 patients followed ten years or more had a 15% risk revision due to DM specific complications during their lifetime and 10% more risk associated with loosening (6%), periprosthetic fracture (2%) and infection (2%).
The variables involved in a robotic THA can exceed 52: many parameters as pelvic orientation with CT scan, templating, offset, and leg-length, acetabular reaming, femoral osteotomy, mapping the anatomy; predefining safe zones, robotic execution, femoral head size, thickness of PE etc. with several variables for each parameter, with a total number of variables exceeding 52. This familiar number is the number of cards in a standard deck. The number of possible combinations (factorial 52! = 10^67) to shuffle the cards (and may be to perform a THA) is greater than the number of atoms on earth! Thinking that artificial intelligence and robotics can solve these problems, some surgeons and implant manufacturers have turned to artificial intelligence and robotics. We asked two questions:1) can robot with artificial intelligence really process 52 variables that represent 10^67 combinations? 2) the safety of the technology was ascertained by interrogating Food and Drug Administration (FDA) database about software-related recalls in computer-assisted and robotic arthroplasty [1], between 2017 and 2022.
The best computers can only calculate around 100 thousand billion combinations (10^14), and with difficulty: it takes more than 100 days to arrive at this number of digits (10^14) after the decimal point for the number π (pi). We can, therefore, expect the robot to be imperfect. For the FDA software-related recalls, 4634 units were involved. The FDA determined root causes were: software design (66.6%), design change (22.2%), manufacturing deployment (5.6%), design manufacturing process (5.6%). Among the manufacturers’ reasons for recalls, a specific error was declared in 88.9%. a coding error in 43.8%. 94.4% software-related recalls were classified as class 2. Return of the device was the main action taken by firms (44.4%), followed by software update (38.9%). In the same period, no robot complained about its surgeon! Hip surgeon is as intelligent as a robot and almost twice as safe.
Symptomatic and non-symptomatic hip osteonecrosis related to sickle cell disease (SCD) has a high risk of progression to collapse and total hip arthroplasty (THA) in this disease has a high rate of complications. We asked question about the benefit of performing an IRM to detect and treat with cell therapy an early (stage I or II) contralateral osteonecrosis. 430 consecutive SCD adult (32 years, 18 to 51) patients (225 males) with bilateral osteonecrosis (diagnosed with MRI) were included in this study from 1990 to 2010. One side with collapse was treated with THA and the contralateral without collapse (stage I or II) treated with cell therapy. The volume of osteonecrosis was measured with MRI. For cell therapy, the average total number of mesenchymal stem cells (MSCs) counted as number of colony forming units-fibroblast injected in each hip was 160,000 ± 45,000 cells (range 75,000 to 210,000 cells). At the most recent FU (20 years, range 10 to 30), among the 430 hips treated with cell therapy, 45 hips (10.5%) had collapsed and had required THA at 10 years (range 5 to 14 years) and 380 hips (88%) were without collapse and asymptomatic (or with few symptoms) with a decrease percentage of necrosis on MRI from 45% to 11%. Among the 430 contralateral THA, 96 (22.3%) had required one revision, 28 had a re-revision, and 12 a third re-revision with aseptic loosening (85% of revisions) and/or infection (6% of revisions). Hips undergoing cell therapy were approximately three times less likely to undergo revision or re-revision surgery (p < 0.01) as compared with hips undergoing a primary THA. THA is the usual treatment of collapsed ON in patients with SCD. In this population, it is worth looking with MRI for an early stage on the contralateral hip and performing (when necessary) bone marrow cell implantation during the same anesthesia as for arthroplasty.
We questioned about bearing surface and infection in two populations of patients who had bilateral THA with different bearings performed in the same hospital by the same surgical team from the year 1981 to the year 2010 (mean followup 15 years; 7 to 35). 1) first population (mean age 32 years): Among the 2290 hips, 3 early (less than 12 months) unilateral infections (2 in the controls, 1 in the SCD), and 59 late unilateral infections: 23 (1.4%) in 1640 THAs control, versus 36 (5.5%) in the SCD 650 THAs (P < 0.0001) during the observation period of 35 years.
When contralateral hip of same patient is control, PE components are more prone to infection than those involving ceramic-on-ceramic.
It is unknown whether the risk of periprosthetic femoral fracture is the same in patients with two different bearing surfaces, ceramic on ceramic (CoC) and ceramic on polyethylene (CoP). We retrospectively reviewed selected 126 patients (252 hips) with bilateral THA (one ceramic-ceramic, AL/AL and the contralateral ceramic-polyethylene, AL/PE) who had THA performed between from 1981 to 1985 for osteonecrosis. Surgery was performed in patients who were average 50 years (range 30–60) old. The stem was always cemented and the same for both sides. The alumina head was 32 mm in diameter. The acetabular component was a polyethylene cup or an alumina cup and was always cemented. The mean follow-up for living patients was 35 years (range 32 to 36), and the mean follow-up for patients who had died was 23 years range 15 to 30). 14 periprosthetic fractures occurred in 252 hips after THA, representing an overall prevalence of 5.5% for hips and 11% for patients. Periprosthetic fractures increased in number with followup: 3 patients (3%) sustained fractures within 10 years of their primary implantation, 7 within 20 years, 10 within 30 years, 14 (11%) within 35 years. The risk of fracture was influenced (p=0.01) by the bearing surfaces at the time of prosthetic implantation, low (1%) for ceramic on ceramic (1/14 fractures; 1/126 hips), higher (10%) for ceramic on PE (13/14; 13/126). When the contralateral hip of the same patient is the control, the long-term risk of periprosthetic fracture on the side with PE cup is greater (10%) than on the side with ceramic/ceramic bearing.
Definitive proof is lacking on mesenchymal stem cell (MSCs) cellular therapy to regenerate bone if biological potential is insufficient. High number of MSCs after GMP expansion may solve the progenitor insufficiency at the injury but clinical trials are pending. A prospective, multicenter, multinational Phase I/IIa interventional clinical trial was designed under the EU-FP7 REBORNE Project to evaluate safety and early efficacy of autologous expanded MSCs loaded on biomaterial at the fracture site in diaphyseal and/or metaphysodiaphyseal fractures (femur, tibia, humerus) nonunions. The trial included 30 recruited patients among 5 European centres in France, Spain, Germany, and Italy. Safety endpoints (local and general complication rate) and secondary endpoints for early efficacy (number of patients with clinically and radiologically proven bone healing at 12 and 24 weeks) were established. Cultured MSCs from autologous bone marrow, expanded under GMP protocol was the Investigational Medicinal Product, standardised in the participating countries confirming equivalent cell production in all the contributing GMP facilities. Cells were mixed with CE-marked biphasic calcium phosphate biomaterial in the surgical setting, at an implanted dose of 20−106 cells per cc of biomaterial (total 10cc per case) in a single administration, after debridement of the nonunion.Background
Methods
Total hip arthroplasty (THA) has been efficacious for treating hip fractures. However, in these patients with fractures a widely variable prevalence of dislocation has been reported, partly because of varying durations of follow-up for this specific end-point. The purpose of the present study was to determine the risk of dislocation as a function of time after total hip arthroplasty in these patients with fractures and to investigate if constrained liners influence the cumulative risk of dislocation. Between 2000 and 2005, 425 patients with neck fracture underwent primary THA using a constrained acetabular liner (Cemented retentive cup, Groupe lépine, Genay, France). The results of these 425 constrained acetabular liners were compared with 380 THA without constrained liners performed for neck fractures between 1994 and 1999 in the same hospital. All patients were followed for a minimum of 5 years for radiographic evidence of implant failure. The patients were followed at routine intervals and were specifically queried about dislocation. The cumulative risk of dislocation was calculated with use of the Kaplan-Meier method. For patients without constrained liners, the cumulative risk of a first-time dislocation was 5% at one month and 12% at one year and then rose at a constant rate of approximately 2% every five years to 17% at five years, 19% at ten years, 21% at 15 years for patients who were alive and had not had a revision by that time. For patients with constrained liners, the cumulative risk of a first-time dislocation was 1% at one month, 2% at one year and then did not changed at 5 years and at 10 years for patients who were alive and had not had a revision by that time. Multivariate analysis revealed that the relative risk of dislocation for female patients (as compared with male patients) was 2.1 and that the relative risk for patients who were 80 years old or more (as compared with those who were less than 80 years old) was 1.5. Two underlying diagnoses - cognitively impaired patients or neurologic desease—were also associated with a significantly greater risk of dislocation. At minimum 7 year follow up (range 5 10 yrs), there were 8 radiographic failures (dislocations) of the 425 constrained liners (2%), and no loosenings were noted. The cumulative long-term risk of dislocation for patients with hip fractures is considerably greater than has been reported in short-term studies. The incidence of dislocation is highest in the first year after arthroplasty and then continues at a relatively constant rate for the life of the arthroplasty. Patients at highest risk are old female patients and those with a diagnosis of neurologic desease. Constrained liners in these patients is an efffective technique to prevent post operative hip dislocation.Results
Conclusions
This study reports the results of percutaneous autologous bone marrow grafting in 62 patients with corticosteroids treatment who had one hip osteonecrosis treated with bone marrow (BM) injection and the other contralateral hip osteonecrosis with core decompression (CD) alone. Only patients with bilateral symptomatic osteonecrosis and with those hips at stage I or II (as defined by Steinberg) were included in this study. Between 1988 and 1995, 62 consecutive patients (28 males and 34 females) were included in this study. These patients had a mean age of 31 years (range 18 to 34 years) at the time of the onset of symptoms. The average follow-up was 17 years (range, 15 to 20 years). An average of 152 + 16 milliliters of marrow was aspirated from the iliac crest. The number of stroma progenitor that was transplanted was estimated by counting the Fibroblast Colony Forming Units which express type I and type III collagen. The bone marrow graft obtained after concentration contained average 4889 + 716 progenitors per cubic centimeter (range 3515 to 6293 per cubic centimeter). Each hip received a mean number of thirty cubic centimeters of bone marrow graft (range 27 to 35 cubic centimeters). The average total number of CFU-F injected in each hip was therefore 147 × 103 cells (range 119 × 103 to 195 × 103 cells).Introduction
Material and Methods
From a theoritical point of vue, experience is an important factor in obtaining a satisfactory result in arthroplasty surgery. We wished to determine whether standard posterior stabilized total knee replacement (PS TKA) performed by young surgeons (Group A) increased rates of mortality and complications compared with PS TKA performed by senior surgeons (Group B) using the same model of arthroplasty. Between 1990 and 1995, 195 patients underwent 250 total knee arthroplasties in the same orthopaedic university department of the hospital by two senior surgeons (100 TKA; Group B) and 12 younger surgeons without senior assistance (150 TKA; Group A). The procedures were undertaken consecutively and the implant was always the same. There were no significant pre-operative differences between the groups in terms of age, gender, height, weight, body mass index, diagnosis, comorbidity and duration of follow-up, which was more than 15 years in both groups. Pre-and postoperative assessments were made according to the system of the Knee Society. The preoperative and postoperative deformities were measured on weight-bearing radiographs of the whole limb (hip-knee-ankle angle). The mean Knee Society knee and functional scores were not significantly different (p = 0.125) pre-operatively: 37.5 points (16 to 53) and 15 points (0 to 20) respectively in the Group B, and 36.0 points (10 to 58) and 17 points (0 to 30) respectively in the Group A; and at final follow-up (p = 0.145): 91 points (42 to 100) and 82 points (25 to 100) respectively in the Group B, and 89 points (58 to 100) and 84 points (35 to 100) respectively in the Group A. The rate of survival at ten years, with revision as the endpoint for failure, was 96% (95% CI, 93 to 100) in both groups; at fifteen years 91% (95% CI, 85 to 97) in group B, and 92% (95% CI, 90 to 94) in group A. There were no significant differences in revision rates in Group B or Group A (p = 0.735). In the Group B group, 1 knee (0.6%) revised for osteolysis, 1 (0.6%) deep infection, 1 (0.6%) aseptic loosening, and 1 (0.6%) for fracture. In the Group A, 1 knee (1%) revised for deep infection, none for osteolysis and 2 (2%) for aseptic loosening, and one for dislocation. In this series surgeons in the early stages of their careers achieved the same results as seniors; so this study is very reassuring for patients undergoing surgery in a university hospital. Our study has however limitations. All the patients received cemented TKA in a large-volume centre specialising in joint reconstruction. It is not a randomised-controlled trial; but it would be impossible to perform one. Would really patients sign up to a study where they would be randomised between an inexperienced and experienced surgeon? What is difficult to assess is how the ‘learning curve’ of one implant affects the ‘learning curve’ for a different implant.
Maltracking or subluxation is one of the complication of patellofemoral arthroplasty (PFA). The purpose of this investigation was to measure femoral component rotational alignment in PFA using a standard computed tomography (CT) scanner. Second, apply this technique to two groups; a control group of patients with well functioning PFA and a study of a group of patients with patellofemoral problems as maltracking or subluxation. Data was analyzed from our center that has continuously performed PFA for isolated patellofemoral degenerative disease since 1978. Patients were included if they had a minimum four year follow up. A total of 124 patients (149 knees) were treated with PFA. There were 39 men and 85 women who had a mean age of 64 years (range, 46 to 78 years). A pre-operative and post-operative CT scan is performed in our center for all the patients since this period to assess femoro-patellar malalignment. The trochlear twist angle was determined using the single axial CT image through the femoral epi-condyles. To determine whether the femoral component was in excessive internal or external rotation, measurements were done on the post-operative CT scan and the trochlear twist angle of the femoral component was compared to the pre-operative trochlear twist angle. At a mean follow up of 13 years (range, 4 to 30 years), overall prosthetic survival and preservation was 91 per cent. There were 112 knees (75 per cent) with good or excellent clinical results (Knee Society score of 80 points or more). Revision to total knee replacement for femoro-tibial disease progression was necessary in 9 knees (6 per cent). Complications related to the patellofemoral arthroplasty (28 knees) included : residual pain or mechanical symptom 10 (7 per cent) requiring other ancillary procedures ; maltracking or subluxation 18 (12%) with component revision in 10 knees; Radiographic findings show 2 component loosenings and 1 patella fracture. There was no incidence of infection or component wear. The group with patellofemoral complications had excessive (p less than 0.01) femoral internal component rotation. This excessive combined internal rotation was directly proportional to the severity of the patellofemoral complication. Small amounts of internal rotation (1–4 degrees) correlated with pain. Moderate combined internal rotation (5–10 degrees) with lateral tracking and patellar tilting. Large amounts of combined internal rotational (10–17 degrees) correlated with patellar sub-luxation, early patellar dislocation or late patellar prosthesis failure (fracture of the patella or loosening of the patella button). The control group (112 knees without complications) was in external rotation (10-0 degrees). This study showed that increasing amounts of excessive internal rotational malalignment resulted in more severe patellofemoral complications.